These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34643822)

  • 21. Pharmacological treatment of acquired QT prolongation and torsades de pointes.
    Thomas SH; Behr ER
    Br J Clin Pharmacol; 2016 Mar; 81(3):420-7. PubMed ID: 26183037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive factors of ventricular fibrillation triggered by pause-dependent torsades de pointes associated with acquired long QT interval: role of QT dispersion and left ventricular function.
    Da Costa A; Chalvidan T; Belounas A; Messier M; Viallet M; Mansour H; Lamaison D; Djiane P; Isaaz K
    J Cardiovasc Electrophysiol; 2000 Sep; 11(9):990-7. PubMed ID: 11021469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between serum bepridil concentration and corrected QT interval.
    Matsui K; Mukai Y; Sakakura K; Wada K; Nakamura T; Kawabata A; Terakawa N; Hayakawa N; Kusano K; Hosomi K; Yokoyama S; Takada M
    Int J Clin Pharmacol Ther; 2021 Jan; 59(1):63-70. PubMed ID: 33026317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent Torsades with Refractory QT Prolongation in a 54-Year-Old Man.
    Guess J; Hubel K; Wiggins A; Madigan CG; Bunin J
    Am J Case Rep; 2018 Dec; 19():1515-1518. PubMed ID: 30568157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Torsades de pointes ventricular tachycardia induced by intravenous amiodarone].
    Makai A; Rudas L; Liszkai G; Fazekas T
    Orv Hetil; 2003 Feb; 144(5):241-7. PubMed ID: 12647553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug therapy for torsade de pointes.
    Banai S; Tzivoni D
    J Cardiovasc Electrophysiol; 1993 Apr; 4(2):206-10. PubMed ID: 8269292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Rare Presentation of Levetiracetam-Induced Torsades De Pointes.
    Mann H; Kusayev J; Pandey S; Aryal B; Solaimanzadeh I
    Cureus; 2023 Jun; 15(6):e40866. PubMed ID: 37492848
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dofetilide-induced long QT and torsades de pointes.
    Aktas MK; Shah AH; Akiyama T
    Ann Noninvasive Electrocardiol; 2007 Jul; 12(3):197-202. PubMed ID: 17617063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. QT interval prolongation and torsades de pointes due to erythromycin lactobionate.
    Oberg KC; Bauman JL
    Pharmacotherapy; 1995; 15(6):687-92. PubMed ID: 8602374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Torsades de Pointes and Prolonged Self-Terminating Ventricular Fibrillation Induced by Amiodarone.
    Tziatzios GD; Didagelos M; Tziatzios I; Hadjimiltiades S; Karamitsos T
    Cureus; 2020 Nov; 12(11):e11693. PubMed ID: 33391927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Torsade de pointes associated with severe bradycardia after induction of general anesthesia].
    Hamaguchi E; Kawano H; Kawahito S; Kitahata H; Oshita S
    Masui; 2011 Sep; 60(9):1097-100. PubMed ID: 21950046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.
    Eckardt L; Haverkamp W; Mertens H; Johna R; Clague JR; Borggrefe M; Breithardt G
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):425-34. PubMed ID: 9733356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Torsades de pointes initiated by slow ventricular stimulation].
    Fontaine G; Frank R; Lascault G; Tonet JL; Fillette F; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Aug; 76(8):918-24. PubMed ID: 6414425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.
    Gilmour RF; Riccio ML; Locati EH; Maison-Blanche P; Coumel P; Schwartz PJ
    J Am Coll Cardiol; 1997 Jul; 30(1):209-17. PubMed ID: 9207644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amisulpride overdose is frequently associated with QT prolongation and torsades de pointes.
    Isbister GK; Balit CR; Macleod D; Duffull SB
    J Clin Psychopharmacol; 2010 Aug; 30(4):391-5. PubMed ID: 20531221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked QT prolongation and torsades de pointes secondary to acute ischemia in an elderly man taking dofetilide for atrial fibrillation: a cautionary tale.
    Nagra BS; Ledley GS; Kantharia BK
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):191-5. PubMed ID: 16211208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
    Yamamoto H; Bando S; Nishikado A; Hamai K; Yamamoto K; Shinohara A
    Kokyu To Junkan; 1991 Mar; 39(3):261-5. PubMed ID: 2047605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.